| 1 | [SID51089817] | Active | EC50 | 1.42 | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity [AID1902, Type: confirmatory] | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | EC50 | 1.42 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity | | AID | 1902 | | BioAssay type | confirmatory | | Target | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] | | PubMed | | | Data Table |  |
|
| 2 | [SID51089817] | Active | EC50 | 2.317 | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus [AID1900, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | EC50 | 2.317 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus | | AID | 1900 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID51089817] | Active | EC50 | 2.75 | Absorbance Microorganism-Based Dose Response HTS to Identify Inhibitors of Streptokinase Expression [AID1914, Type: confirmatory] | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | EC50 | 2.75 [uM] | | BioAssay | Absorbance Microorganism-Based Dose Response HTS to Identify Inhibitors of Streptokinase Expression | | AID | 1914 | | BioAssay type | confirmatory | | Target | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] | | PubMed | | | Data Table |  |
|
| 4 | [SID51089817] | Active | Potency | 4.1095 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | Potency | 4.1095 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID51089817] | Active | Potency | 4.1095 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | Potency | 4.1095 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID51089817] | Active | Potency | 4.1095 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | Potency | 4.1095 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID51089817] | Active | Potency | 4.4668 | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | Potency | 4.4668 [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|
| 8 | [SID51089817] | Active | Potency | 4.4668 | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | Potency | 4.4668 [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|
| 9 | [SID51089817] | Active | Potency | 4.6109 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | Potency | 4.6109 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 10 | [SID51089817] | Active | Potency | 4.6109 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | Potency | 4.6109 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 11 | [SID51089817] | Active | Potency | 4.6109 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | Potency | 4.6109 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 12 | [SID51089817] | Active | EC50 | 9.325 | Luminescence Microorganism-Based Dose Response HTS to Identify Compounds Cytotoxic to Streptococcus [AID1915, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | EC50 | 9.325 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Response HTS to Identify Compounds Cytotoxic to Streptococcus | | AID | 1915 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID51089817] | Active | Potency | 10 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID51089817] | Active | Potency | 10 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 15 | [SID51089817] | Active | Potency | 12.5893 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 16 | [SID51089817] | Active | Potency | 12.5893 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 17 | [SID51089817] | Active | Potency | 14.581 | qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation [AID540253, Type: confirmatory] | snurportin-1 [Homo sapiens] [gi:5031833] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation | | AID | 540253 | | BioAssay type | confirmatory | | Target | snurportin-1 [Homo sapiens] [gi:5031833] | | PubMed | | | Data Table |  |
|
| 18 | [SID51089817] | Active | Potency | 16.3601 | Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity [AID504648, Type: confirmatory] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | Potency | 16.3601 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity | | AID | 504648 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID124753343] | Active | Potency | 18.6548 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 124753343 | | CID | 24892529 | | Outcome | Active | | Potency | 18.6548 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 20 | [SID124753343] | Active | Potency | 18.6548 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 124753343 | | CID | 24892529 | | Outcome | Active | | Potency | 18.6548 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 21 | [SID124753343] | Active | Potency | 18.6548 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 124753343 | | CID | 24892529 | | Outcome | Active | | Potency | 18.6548 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 22 | [SID51089817] | Active | Potency | 20.5962 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 23 | [SID51089817] | Active | Potency | 20.5962 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 24 | [SID51089817] | Active | Potency | 20.5962 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 25 | [SID51089817] | Active | Potency | 20.5962 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 26 | [SID51089817] | Active | Potency | 56.2341 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | Potency | 56.2341 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 27 | [SID51089817] | Active | | | Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7 [AID463210, Type: screening] | caspase 7, apoptosis-related cysteine peptidase [Homo sapiens] [gi:55960760] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7 | | AID | 463210 | | BioAssay type | screening | | Target | caspase 7, apoptosis-related cysteine peptidase [Homo sapiens] [gi:55960760] | | PubMed | | | Data Table |  |
|
| 28 | [SID51089817] | Active | | | Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3 [AID463141, Type: screening] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3 | | AID | 463141 | | BioAssay type | screening | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 29 | [SID51089817] | Active | | | Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3 [AID463141, Type: screening] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3 | | AID | 463141 | | BioAssay type | screening | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 30 | [SID51089817] | Active | | | Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3 [AID463141, Type: screening] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3 | | AID | 463141 | | BioAssay type | screening | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 31 | [SID51089817] | Active | | | Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3 [AID463141, Type: screening] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3 | | AID | 463141 | | BioAssay type | screening | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 32 | [SID51089817] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 33 | [SID51089817] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 34 | [SID51089817] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 35 | [SID51089817] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 36 | [SID51089817] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 37 | [SID51089817] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 38 | [SID51089817] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 39 | [SID51089817] | Active | | | Counterscreen for biased ligands (antagonists) of the melanocortin 4 receptor (MC4R): TRFRET-based cell-based high throughput assay to identify nonselective inhibitors of cAMP signaling [AID602193, Type: screening] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | Counterscreen for biased ligands (antagonists) of the melanocortin 4 receptor (MC4R): TRFRET-based cell-based high throughput assay to identify nonselective inhibitors of cAMP signaling | | AID | 602193 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID51089817] | Active | | | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line [AID463079, Type: screening] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line | | AID | 463079 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID51089817] | Active | | | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588674, Type: screening] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588674 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID51089817] | Active | | | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay [AID602449, Type: screening] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay | | AID | 602449 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID124753343] | Active | | | Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line [AID602250, Type: screening] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 124753343 | | CID | 24892529 | | Outcome | Active | | BioAssay | Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line | | AID | 602250 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID51089817] | Active | | | Single concentration confirmation of uHTS inhibitor hits of the mitochondrial permeability transition pore via a fluorescent based assay [AID624504, Type: screening] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS inhibitor hits of the mitochondrial permeability transition pore via a fluorescent based assay | | AID | 624504 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID51089817] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 46 | [SID51089817] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 47 | [SID51089817] | Active | | | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R [AID540295, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R | | AID | 540295 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 48 | [SID51089817] | Active | | | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R [AID540295, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R | | AID | 540295 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 49 | [SID51089817] | Active | | | TRFRET-based cell-based high throughput confirmation assay for biased ligands (antagonists) of the melanocortin 4 receptor (MC4R) [AID602195, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | TRFRET-based cell-based high throughput confirmation assay for biased ligands (antagonists) of the melanocortin 4 receptor (MC4R) | | AID | 602195 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 50 | [SID51089817] | Active | | | TRFRET-based cell-based high throughput confirmation assay for biased ligands (antagonists) of the melanocortin 4 receptor (MC4R) [AID602195, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 51089817 | | CID | 24892529 | | Outcome | Active | | BioAssay | TRFRET-based cell-based high throughput confirmation assay for biased ligands (antagonists) of the melanocortin 4 receptor (MC4R) | | AID | 602195 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|